Sabby Management
MIAMI BEACH, FLfiles as SABBY MANAGEMENT, LLC
$12m in 16 US stocks at the end of 30 June 2026. The top 10 are 94.7% of the money. It changed about 60.5% of the portfolio this quarter.
Value
$12m
Stocks
16
Top 10 share
94.7%
Turnover
60.5%
What changed this quarter
New
Bought for the first time this quarter.
- ToyoTOYO29.1% of the fund
- FarmmiFAMI7.0% of the fund
- CervoMedCRVO6.4% of the fund
- Paranovus Entertainment TechnologyPAVS4.7% of the fund
- Bioaffinity Technologies2.5% of the fund
- Smart PowerrCREG2.2% of the fund
- Sidus SpaceSIDU1.0% of the fund
- NuwellisNUWE0.4% of the fund
Added
Bought more of a stock they already held.
- State STR Spdr S&P 500 ETF TSPY34.2% of the fund+101%
- Tempest TherapeuticsTPST4.7% of the fund+2763%
- BriaCell TherapeuticsBCTX2.2% of the fund+9%
- Revelation BiosciencesREVB1.8% of the fund+112%
Cut
Sold some of their stake.
- SenesTechSNES1.8% of the fund-35%
- Briacell TherapeuticsBCTXL1.4% of the fund-50%
- InMed PharmaceuticalsINM0.6% of the fund-80%
- Briacell TherapeuticsBCTXZ<0.1% of the fund-42%
Sold out
Sold their entire stake.
- Alpha Compute-100%
- Big Tree Cloud HoldingsDSY-100%
- Token CATTC-100%
- POP Culture Group-100%
- Moleculin BiotechMBRX-100%
- Biodexa Pharmaceuticals PLC ADR-100%
- Arcadia BiosciencesRKDA-100%
- TRX GoldTRX-100%
- CAN Fite BiofarmaCANF-100%
- China SXT Pharmaceuticals IN-100%
- Calidi Biotherapeutics-100%
- Bluejay DiagnosticsBJDX-100%
- Lyra TherapeuticsLYRA-100%
- BNB PlusBNBX-100%
Holdings
- State STR Spdr S&P 500 ETF TSPY
- Share
- 34.2%
- Value
- $4m
- Shares
- 5,500
+101%
- Bioaffinity Technologies
- Share
- 2.5%
- Value
- $296,905
- Shares
- 365,647
New
- Smart PowerrCREG
- Share
- 2.2%
- Value
- $263,214
- Shares
- 127,774
New
- Briacell TherapeuticsBCTXL
- Share
- 1.4%
- Value
- $169,441
- Shares
- 190,383
-50%
- Briacell TherapeuticsBCTXZ
- Share
- <0.1%
- Value
- $11,464
- Shares
- 120,802
-42%
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| State STR Spdr S&P 500 ETF TSPY | 34.2% | $4m | 5,500 | +101% |
| ToyoTOYO | 29.1% | $4m | 503,846 | New |
| FarmmiFAMI | 7.0% | $840,307 | 3,515,929 | New |
| CervoMedCRVO | 6.4% | $771,528 | 248,880 | New |
| Tempest TherapeuticsTPST | 4.7% | $567,527 | 511,286 | +2763% |
| Paranovus Entertainment TechnologyPAVS | 4.7% | $560,519 | 75,440 | New |
| Bioaffinity Technologies | 2.5% | $296,905 | 365,647 | New |
| Smart PowerrCREG | 2.2% | $263,214 | 127,774 | New |
| BriaCell TherapeuticsBCTX | 2.2% | $261,536 | 80,721 | +9% |
| Revelation BiosciencesREVB | 1.8% | $216,899 | 210,582 | +112% |
| SenesTechSNES | 1.8% | $211,216 | 141,756 | -35% |
| Briacell TherapeuticsBCTXL | 1.4% | $169,441 | 190,383 | -50% |
| Sidus SpaceSIDU | 1.0% | $121,889 | 43,377 | New |
| InMed PharmaceuticalsINM | 0.6% | $69,704 | 44,970 | -80% |
| NuwellisNUWE | 0.4% | $49,935 | 16,372 | New |
| Briacell TherapeuticsBCTXZ | <0.1% | $11,464 | 120,802 | -42% |
Options (7)
- State STR Spdr S&P 500 ETF T
- Type
- Put
- Value
- $54m
- Contracts
- 725
- State STR Spdr S&P 500 ETF T
- Type
- Call
- Value
- $15m
- Contracts
- 205
- Ishares TR
- Type
- Call
- Value
- $13m
- Contracts
- 442
- Ishares TR
- Type
- Put
- Value
- $13m
- Contracts
- 441
- Abivax SA
- Type
- Call
- Value
- $1m
- Contracts
- 82
- Sidus Space
- Type
- Put
- Value
- $816,305
- Contracts
- 2,905
- Zevra Therapeutics
- Type
- Put
- Value
- $612,318
- Contracts
- 427
| Company | Type | Value | Contracts |
|---|---|---|---|
| State STR Spdr S&P 500 ETF T | Put | $54m | 725 |
| State STR Spdr S&P 500 ETF T | Call | $15m | 205 |
| Ishares TR | Call | $13m | 442 |
| Ishares TR | Put | $13m | 441 |
| Abivax SA | Call | $1m | 82 |
| Sidus Space | Put | $816,305 | 2,905 |
| Zevra Therapeutics | Put | $612,318 | 427 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 7.5% since 30 June 2025.
Where the money is
Technology33.8%
Health care16.1%
Everyday goods7.0%
Materials1.8%
Media & telecom1.0%
Other40.3%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.